122 related articles for article (PubMed ID: 38754632)
1. Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis.
Ran B; Ren X; Lin X; Teng Y; Xin F; Ma W; Zhao X; Li M; Wang J; Wang C; Sun L; Zhang J
J Control Release; 2024 Jun; 370():811-820. PubMed ID: 38754632
[TBL] [Abstract][Full Text] [Related]
2. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TGF-β1/Smad3 signaling by compound 5aa: A potential treatment for idiopathic pulmonary fibrosis.
An B; Fang Y; Wang L; Nie W; Wang M; Nie H; Wu C; Wang R
Bioorg Chem; 2024 Jun; 147():107374. PubMed ID: 38636433
[TBL] [Abstract][Full Text] [Related]
4. Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis.
Wang D; Gong L; Li Z; Chen H; Xu M; Rong R; Zhang Y; Zhu Q
J Ethnopharmacol; 2021 Dec; 281():114522. PubMed ID: 34391863
[TBL] [Abstract][Full Text] [Related]
5. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.
Yu W; Guo F; Song X
Pharm Biol; 2017 Dec; 55(1):450-455. PubMed ID: 27937011
[TBL] [Abstract][Full Text] [Related]
6. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
[TBL] [Abstract][Full Text] [Related]
7. Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo.
Ma Z; Zhao C; Chen Q; Yu C; Zhang H; Zhang Z; Huang W; Shen Z
Pulm Pharmacol Ther; 2018 Dec; 53():100-106. PubMed ID: 30394340
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of microbial biosurfactants produced by Bacillus halotolerans and Candida parapsilosis on bleomycin-induced pulmonary fibrosis in mice: Impact of antioxidant, anti-inflammatory and anti-fibrotic properties via TGF-β1/Smad-3 pathway and miRNA-326.
Mousa AM; Nooman MU; Abbas SS; Gebril SM; Abdelraof M; Al-Kashef AS
Toxicol Appl Pharmacol; 2024 May; 486():116939. PubMed ID: 38643951
[TBL] [Abstract][Full Text] [Related]
10. Shengxian decoction improves lung function in rats with bleomycin-induced idiopathic pulmonary fibrosis through the inhibition of PANoptosis.
Liang Y; Yan Y; Liu N; Wang J; Fang C
J Ethnopharmacol; 2024 Jul; 329():118153. PubMed ID: 38604513
[TBL] [Abstract][Full Text] [Related]
11. Dual inhibition of α
Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
[TBL] [Abstract][Full Text] [Related]
12. Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles.
Hu Y; Li M; Zhang M; Jin Y
Int J Pharm; 2018 Nov; 551(1-2):212-222. PubMed ID: 30227240
[TBL] [Abstract][Full Text] [Related]
13. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
[TBL] [Abstract][Full Text] [Related]
14. AAV6-Mediated IL-10 Expression in the Lung Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Kurosaki F; Uchibori R; Sehara Y; Saga Y; Urabe M; Mizukami H; Hagiwara K; Kume A
Hum Gene Ther; 2018 Nov; 29(11):1242-1251. PubMed ID: 29598007
[TBL] [Abstract][Full Text] [Related]
15. Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.
Herrmann FE; Wollin L; Wirth J; Gantner F; Lämmle B; Wex E
Br J Pharmacol; 2017 Nov; 174(21):3848-3864. PubMed ID: 28810065
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis.
Zhou LL; Wang M; Liu F; Lu YZ; Song LJ; Xiong L; Xiang F; He XL; Shuai SY; Xin JB; Ye H; Yu F; Ma WL
Toxicol Lett; 2019 Mar; 303():1-8. PubMed ID: 30572104
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.
Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y
Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204
[TBL] [Abstract][Full Text] [Related]
18. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
[TBL] [Abstract][Full Text] [Related]
19. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota.
Tong L; Hao H; Zhang Z; Lv Y; Liang X; Liu Q; Liu T; Gong P; Zhang L; Cao F; Pastorin G; Lee CN; Chen X; Wang JW; Yi H
Theranostics; 2021; 11(17):8570-8586. PubMed ID: 34373759
[No Abstract] [Full Text] [Related]
20. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
Miao Y; Wang Y; Bi Z; Huang K; Gao J; Li X; Li S; Wei L; Zhou H; Yang C
BMC Pulm Med; 2023 Mar; 23(1):94. PubMed ID: 36949426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
